Acutus Medical, Inc.
AFIB · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $7 | $5 | $4 | $4 |
| % Growth | 35.6% | 27.6% | 13.8% | – |
| Cost of Goods Sold | $6 | $5 | $4 | $4 |
| Gross Profit | $1 | $0 | -$0 | -$0 |
| % Margin | 14.1% | 7.1% | -8.3% | -0.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $2 | $2 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1 | -$2 | -$0 | $0 |
| Operating Expenses | $2 | -$0 | $2 | $3 |
| Operating Income | -$0 | $0 | $0 | -$1 |
| % Margin | -3.8% | 9.3% | 7.3% | -15.9% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$1 |
| Pre-Tax Income | -$1 | -$1 | -$0 | -$2 |
| Tax Expense | $0 | $5 | $0 | $0 |
| Net Income | -$1 | -$6 | -$1 | -$2 |
| % Margin | -19.7% | -106.5% | -22.1% | -44.7% |
| EPS | -0.047 | -0.19 | -0.031 | -0.055 |
| % Growth | 75.3% | -516.9% | 43.6% | – |
| EPS Diluted | -0.047 | -0.19 | -0.031 | -0.055 |
| Weighted Avg Shares Out | 30 | 30 | 30 | 30 |
| Weighted Avg Shares Out Dil | 30 | 30 | 30 | 30 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $2 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $1 | $1 | -$0 |
| % Margin | 4.5% | 15.9% | 34% | -8.6% |